LGT Fund Management’s Idexx Laboratories IDXX Stock Holding History

LGT Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Buy	1,870 +990	+113%	+$635K	0.05%	195
2025 Q4	$600K	Buy	880 +370	+73%	+$252K	0.05%	168
2025 Q3	$316K	Sell	510 -40	-7%	-$24.3K	0.03%	208
2025 Q2	$295K	Sell	550 -40	-7%	-$19.1K	0.03%	210
2025 Q1	$248K	Buy	+590	New	+$256K	0.02%	220
2022 Q2	–	Sell	-500	Closed	-$277K	–	192
2022 Q1	$277K	Sell	500 -4,800	-91%	-$2.52M	0.04%	171
2021 Q4	$3.49M	Buy	+5,300	New	+$3.33M	1.01%	38

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LGT Fund Management's IDXX Position: Q1 2026 in Review

LGT Fund Management increased its Idexx Laboratories (IDXX) stake by 113% in Q1 2026, buying an estimated $635K and bringing the position to 1,870 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #195.

LGT Fund Management first reported a position in IDXX in Q4 2021 and has held it in 7 quarters since. The position peaked at $3.49M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

LGT Fund Management held 1,870 shares of Idexx Laboratories worth $1.05M as of Q1 2026.
LGT Fund Management bought 990 Idexx Laboratories shares in Q1 2026, an estimated $635K.
Idexx Laboratories made up 0.05% of LGT Fund Management's portfolio in Q1 2026, its #195 holding.
LGT Fund Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 7 quarters since.
LGT Fund Management's Idexx Laboratories position peaked at $3.49M in Q4 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on LGT Fund Management's 13F filing for Q1 2026, filed 28 Apr 2026.